Given numerous studies demonstrating aggressive nutrition’s vital impact on health in the CF population and the subsequent use of PERT, this review will explore current updates on the clinical presentation of patients with PI CF, the effects of PERT, various nuances to consider, and special considerations of PERT therapy in the age of CFTR modulators. Here, CFTR is linked to cystic fibrosis.